XLON
PAM
Market cap19mUSD
Oct 29, Last price
21.25GBP
1D
0.00%
1Q
-5.56%
Jan 2017
30.77%
Name
Creightons PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating both within the United Kingdom and across international markets, Creightons Plc, along with its subsidiaries, specializes in the development, manufacturing, and marketing of a wide array of personal care items and fragrances. Their diverse product portfolio covers categories such as hair care, skin care, bath and body essentials, wellbeing solutions, and male grooming products. In addition to offering their own branded goods, the company provides private label manufacturing for major high street retailers and supermarket chains, and undertakes contract manufacturing for other brand owners. Their extensive brand family includes popular lines like Argan Smooth, Balance Active Formula, Creightons Frizz No More, Feather & Down, and The Curl Company, among many others. Customers also have the convenience of purchasing these products through online platforms. Established in 1954, Creightons Plc maintains its headquarters in Peterborough, UK.
Key people
Paul Forster
Non-Executive Chairman of the Board · since 2024
Mohammed Qadeer
Group Chief Financial Officer, Executive Director · since 2025
Philippa Clark
Group Managing Director, Executive Director · since 2024
Martin Stevens
Deputy Group Managing Director, Executive Director · since 2024
Brian Geary
Non-Executive Director · since 2024
William Glencross
Non-Executive Director · since 2006
Nicholas O'Shea
Non-Executive Director · since 2025
Non-Executive Independent Director · since 2025
Paul Watts
Non-Executive Independent Director · since 2025
Headquarters & legal address
1210 LINCOLN ROAD
WERRINGTON
PETERBOROUGH, PTE PE4 6ND
GB
WERRINGTON
PETERBOROUGH, PTE PE4 6ND
GB
Previous name
CREIGHTONS PLC
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||